South Korea · Delayed Price · Currency is KRW Narae Nanotech Statistics
Total Valuation
Narae Nanotech has a market cap or net worth of KRW 75.65 billion. The enterprise value is 21.46 billion.
| Market Cap | 75.65B |
| Enterprise Value | 21.46B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Narae Nanotech has 11.06 million shares outstanding. The number of shares has decreased by -0.63% in one year.
| Current Share Class | 11.06M |
| Shares Outstanding | 11.06M |
| Shares Change (YoY) | -0.63% |
| Shares Change (QoQ) | -2.66% |
| Owned by Insiders (%) | 49.14% |
| Owned by Institutions (%) | n/a |
| Float | 5.59M |
Valuation Ratios
The trailing PE ratio is 1.17.
| PE Ratio | 1.17 |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | 0.58 |
| P/TBV Ratio | 0.59 |
| P/FCF Ratio | 6.03 |
| P/OCF Ratio | 5.45 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.09, with an EV/FCF ratio of 1.71.
| EV / Earnings | 0.33 |
| EV / Sales | 0.34 |
| EV / EBITDA | 3.09 |
| EV / EBIT | 11.89 |
| EV / FCF | 1.71 |
Financial Position
The company has a current ratio of 4.84, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.84 |
| Quick Ratio | 3.84 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.02 |
| Debt / FCF | 0.01 |
| Interest Coverage | 1.15 |
Financial Efficiency
Return on equity (ROE) is 64.87% and return on invested capital (ROIC) is 1.93%.
| Return on Equity (ROE) | 64.87% |
| Return on Assets (ROA) | 0.75% |
| Return on Invested Capital (ROIC) | 1.93% |
| Return on Capital Employed (ROCE) | 1.37% |
| Weighted Average Cost of Capital (WACC) | 9.00% |
| Revenue Per Employee | 423.33M |
| Profits Per Employee | 425.00M |
| Employee Count | 151 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 4.20 |
Taxes
In the past 12 months, Narae Nanotech has paid 16.57 billion in taxes.
| Income Tax | 16.57B |
| Effective Tax Rate | 20.52% |
Stock Price Statistics
The stock price has increased by +101.18% in the last 52 weeks. The beta is 0.57, so Narae Nanotech's price volatility has been lower than the market average.
| Beta (5Y) | 0.57 |
| 52-Week Price Change | +101.18% |
| 50-Day Moving Average | 5,488.60 |
| 200-Day Moving Average | 4,681.38 |
| Relative Strength Index (RSI) | 63.13 |
| Average Volume (20 Days) | 32,175 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Narae Nanotech had revenue of KRW 63.92 billion and earned 64.18 billion in profits. Earnings per share was 5,837.94.
| Revenue | 63.92B |
| Gross Profit | 15.25B |
| Operating Income | 1.80B |
| Pretax Income | 80.74B |
| Net Income | 64.18B |
| EBITDA | 6.94B |
| EBIT | 1.80B |
| Earnings Per Share (EPS) | 5,837.94 |
Balance Sheet
The company has 54.33 billion in cash and 144.30 million in debt, with a net cash position of 54.18 billion or 4,899.38 per share.
| Cash & Cash Equivalents | 54.33B |
| Total Debt | 144.30M |
| Net Cash | 54.18B |
| Net Cash Per Share | 4,899.38 |
| Equity (Book Value) | 129.77B |
| Book Value Per Share | 12,038.19 |
| Working Capital | 70.28B |
Cash Flow
In the last 12 months, operating cash flow was 13.88 billion and capital expenditures -1.34 billion, giving a free cash flow of 12.54 billion.
| Operating Cash Flow | 13.88B |
| Capital Expenditures | -1.34B |
| Depreciation & Amortization | 5.14B |
| Net Borrowing | -69.42B |
| Free Cash Flow | 12.54B |
| FCF Per Share | 1,133.63 |
Margins
Gross margin is 23.85%, with operating and profit margins of 2.82% and 100.39%.
| Gross Margin | 23.85% |
| Operating Margin | 2.82% |
| Pretax Margin | 126.31% |
| Profit Margin | 100.39% |
| EBITDA Margin | 10.86% |
| EBIT Margin | 2.82% |
| FCF Margin | 19.61% |
Dividends & Yields
Narae Nanotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.63% |
| Shareholder Yield | 0.63% |
| Earnings Yield | 84.84% |
| FCF Yield | 16.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Narae Nanotech has an Altman Z-Score of 3.08 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.08 |
| Piotroski F-Score | 6 |